Atle Fund Management AB — 13F Holdings

2026 Q1  ·  43 Positions

2026 Q1 Portfolio Activity

In 2026 Q1, Atle Fund Management AB maintained a portfolio of 43 distinct positions. The most significant new addition was JOHNSON & JOHNSON, now representing 3.86% of the total fund value. They heavily accumulated shares in MIRUM PHARMACEUTICALS INC, increasing the position by 118.3%. Conversely, Atle Fund Management AB completely exited their position in UFP Technologies Inc.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
43
Quarter
2026 Q1
Top Holding
LLY (8.7%)
Top 10 Concentration
45.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-43 of 43

Atle Fund Management AB Full Holdings List — 2026 Q1

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
LLY
ELI LILLY & CO
Healthcare 8.67% 10.67% #1
Prev: #1
8.0
8,589 27.6%
P
S
39,722 $26,845,326 2006 Q4 13F Filing 2026-03-31 2026-05-11
MRK
MERCK & CO. INC
Healthcare 7.40% 6.57% #2 1
Prev: #3
4.5
-161,915 -82.7%
P
S
33,853 $22,917,169 2006 Q4 13F Filing 2026-03-31 2026-05-11
TMO
THERMO FISHER S...
Healthcare 4.67% 5.53% #3 1
Prev: #4
2.9
-6,929 -23.2%
P
S
22,986 $14,449,998 2006 Q4 13F Filing 2026-03-31 2026-05-11
ONC
BEONE MEDICINES...
Healthcare 3.92% 3.92% #4 3
Prev: #7
2.6
1,285 3.2%
P
S
41,717 $12,137,163 2006 Q4 13F Filing 2026-03-31 2026-05-11
JNJ
JOHNSON & JOHNS...
Healthcare 3.86% #5
Prev: #—
5.5
92,377
NEW
92,377 $11,943,093 2026 Q1 13F Filing 2026-03-31 2026-05-11
BBIO
BRIDGEBIO PHARM...
Healthcare 3.84% 3.45% #6 2
Prev: #8
1.5
-29,933 -21.2%
P
S
111,363 $11,893,481 2006 Q4 13F Filing 2026-03-31 2026-05-11
VRTX
VERTEX PHARMACE...
Healthcare 3.61% 3.32% #7 2
Prev: #9
2.4
no change no change
P
S
22,984 $11,167,965 2006 Q4 13F Filing 2026-03-31 2026-05-11
ABBV
ABBVIE INC
Healthcare 3.35% 7.89% #8 6
Prev: #2
2.3
no change no change
P
S
108,181 $10,385,799 2006 Q4 13F Filing 2026-03-31 2026-05-11
SYK
STRYKER CORPORA...
Healthcare 3.09% 3.01% #9 2
Prev: #11
2.2
no change no change
P
S
26,835 $9,579,712 2006 Q4 13F Filing 2026-03-31 2026-05-11
ISRG
INTUITIVE SURGI...
Healthcare 3.05% 4.03% #10 4
Prev: #6
4.2
48,529 217.4%
P
S
70,851 $9,444,763 2006 Q4 13F Filing 2026-03-31 2026-05-11
IONS
IONIS PHARMACEU...
Healthcare 3.03% 2.33% #11 4
Prev: #15
1.2
-64,504 -69.8%
P
S
27,873 $9,398,790 2006 Q4 13F Filing 2026-03-31 2026-05-11
MIRM
MIRUM PHARMACEU...
Healthcare 3.03% 2.26% #12 6
Prev: #18
4.2
106,083 118.3%
P
S
195,768 $9,397,540 2006 Q4 13F Filing 2026-03-31 2026-05-11
CVS
CVS HEALTH CORP
Healthcare 2.99% 2.70% #13 1
Prev: #12
1.2
-82,745 -77.7%
P
S
23,773 $9,267,221 2006 Q4 13F Filing 2026-03-31 2026-05-11
RVMD
REVOLUTION MEDI...
Healthcare 2.93% 2.29% #14 2
Prev: #16
4.2
527,061 584.4%
P
S
617,245 $9,077,023 2006 Q4 13F Filing 2026-03-31 2026-05-11
BSX
BOSTON SCIENTIF...
Healthcare 2.86% 3.31% #15 5
Prev: #10
1.1
-68,250 -62.8%
P
S
40,432 $8,844,236 2006 Q4 13F Filing 2026-03-31 2026-05-11
AMGN
AMGEN INC
Healthcare 2.81% 2.29% #16 1
Prev: #17
2.1
no change no change
P
S
21,903 $8,716,028 2006 Q4 13F Filing 2026-03-31 2026-05-11
EW
EDWARDS LIFESCI...
Healthcare 2.67% #17
Prev: #—
4.6
106,518
NEW
106,518 $8,266,658 2022 Q4 13F Filing 2026-03-31 2026-05-11
ALKS
ALKERMES PLC
Healthcare 2.66% 2.16% #18 3
Prev: #21
2.1
no change no change
P
S
242,473 $8,235,520 2006 Q4 13F Filing 2026-03-31 2026-05-11
INCY
INCYTE CORP
Healthcare 2.57% 2.23% #19
Prev: #19
1.0
-20,055 -28.3%
P
S
50,796 $7,974,128 2006 Q4 13F Filing 2026-03-31 2026-05-11
NBIX
NEUROCRINE BIOS...
Healthcare 2.54% 4.29% #20 15
Prev: #5
1.5
-5,111 -5.4%
P
S
89,685 $7,854,470 2006 Q4 13F Filing 2026-03-31 2026-05-11
GILD
GILEAD SCIENCES...
Healthcare 2.31% 1.99% #21 2
Prev: #23
1.4
-2,829 -5.6%
P
S
47,967 $7,156,510 2006 Q4 13F Filing 2026-03-31 2026-05-11
KRYS
KRYSTAL BIOTECH...
Healthcare 2.19% 2.66% #22 9
Prev: #13
2.9
3,726 11.0%
P
S
37,579 $6,793,816 2006 Q4 13F Filing 2026-03-31 2026-05-11
COR
CENCORA INC
Healthcare 2.13% 2.56% #23 9
Prev: #14
1.4
-303 -1.3%
P
S
23,470 $6,603,222 2006 Q4 13F Filing 2026-03-31 2026-05-11
IRTC
IRHYTHM TECHNOL...
Healthcare 2.02% 2.13% #24 2
Prev: #22
0.8
-15,257 -40.6%
P
S
22,322 $6,259,662 2006 Q4 13F Filing 2026-03-31 2026-05-11
INSM
INSMED INC
Healthcare 1.92% 1.55% #25
Prev: #25
3.8
69,565 249.6%
P
S
97,438 $5,955,071 2006 Q4 13F Filing 2026-03-31 2026-05-11
NAMS
NEWAMSTERDAM PH...
Healthcare 1.78% 2.21% #26 6
Prev: #20
0.7
-102,240 -51.9%
P
S
94,796 $5,508,280 2006 Q4 13F Filing 2026-03-31 2026-05-11
CELC
CELCUITY INC
Healthcare 1.66% 1.33% #27 1
Prev: #28
3.7
99,465 237.8%
P
S
141,296 $5,141,208 2006 Q4 13F Filing 2026-03-31 2026-05-11
ABVX
ABIVAX SA
Healthcare 1.54% 1.36% #28 1
Prev: #27
1.6
no change no change
P
S
31,590 $4,783,596 2006 Q4 13F Filing 2026-03-31 2026-05-11
CAH
CARDINAL HEALTH...
Healthcare 1.54% 1.54% #29 3
Prev: #26
3.6
85,212 363.1%
P
S
108,682 $4,768,210 2006 Q4 13F Filing 2026-03-31 2026-05-11
IDYA
IDEAYA BIOSCIEN...
Healthcare 1.30% 1.07% #30
Prev: #30
0.5
-66,305 -68.0%
P
S
31,133 $4,011,494 2006 Q4 13F Filing 2026-03-31 2026-05-11
TNGX
TANGO THERAPEUT...
Healthcare 1.17% #31
Prev: #—
4.0
29,915
NEW
29,915 $3,629,578 2026 Q1 13F Filing 2026-03-31 2026-05-11
SYRE
SPYRE THERAPEUT...
Healthcare 1.13% #32
Prev: #—
4.0
62,735
NEW
62,735 $3,485,807 2026 Q1 13F Filing 2026-03-31 2026-05-11
IRON
DISC MEDICINE I...
Healthcare 1.03% 1.22% #33 4
Prev: #29
3.4
59,288 123.6%
P
S
107,255 $3,188,687 2006 Q4 13F Filing 2026-03-31 2026-05-11
CMPX
COMPASS THERAPE...
Healthcare 0.99% 1.00% #34 2
Prev: #32
0.4
-542,501 -92.8%
P
S
41,831 $3,051,055 2006 Q4 13F Filing 2026-03-31 2026-05-11
UNH
UNIVERSAL HEALT...
Healthcare 0.90% 1.02% #35 4
Prev: #31
1.4
no change no change
P
S
14,636 $2,772,424 2006 Q4 13F Filing 2026-03-31 2026-05-11
DXCM
DEXCOM INC
Healthcare 0.85% 0.84% #36 1
Prev: #35
3.3
544,610 1371.1%
P
S
584,332 $2,639,923 2006 Q4 13F Filing 2026-03-31 2026-05-11
BCAX
BICARA THERAPEU...
Healthcare 0.75% 0.60% #37
Prev: #37
3.3
1,058,271 950.3%
P
S
1,169,634 $2,315,235 2006 Q4 13F Filing 2026-03-31 2026-05-11
SLNO
SOLENO THERAPEU...
Healthcare 0.71% 0.93% #38 5
Prev: #33
2.8
27,449 43.8%
P
S
90,184 $2,207,336 2006 Q4 13F Filing 2026-03-31 2026-05-11
PYXS
PYXIS ONCOLOGY ...
Healthcare 0.52% 0.23% #39
Prev: #39
0.2
-420,209 -68.1%
P
S
197,036 $1,618,053 2006 Q4 13F Filing 2026-03-31 2026-05-11
CRBP
Corbus Pharmace...
Healthcare 0.00% 0.28%
Sold All 😨
(Was: #38)
0.0
-107,255 -100.0%
CLOSED
$— 2006 Q4 13F Filing 2026-03-31 2026-05-11
AUTL
Autolus Therape...
Healthcare 0.00% 0.74%
Sold All 😨
(Was: #36)
0.0
-1,169,634 -100.0%
CLOSED
$— 2006 Q4 13F Filing 2026-03-31 2026-05-11
ACLX
Arcellx Inc
Healthcare 0.00% 0.87%
Sold All 😨
(Was: #34)
0.0
-41,717 -100.0%
CLOSED
$— 2006 Q4 13F Filing 2026-03-31 2026-05-11
UFPT
UFP Technologie...
Healthcare 0.00% 1.63%
Sold All 😨
(Was: #24)
0.0
-22,986 -100.0%
CLOSED
$— 2006 Q4 13F Filing 2026-03-31 2026-05-11
Showing 1-43 of 43 holdings

Unlock Full Atle Fund Management AB Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →